European Journal of Medicinal Chemistry

The European Journal of Medicinal Chemistry publishes research on the design, synthesis and evaluation of bioactive compounds, was founded in 1974 and is published by Elsevier, with a 2025 Journal Impact Factor of 6.7《欧洲药物化学杂志》（European Journal of Medicinal Chemistry）发表活性化合物的设计、合成与评价研究，1974 年创办，由（Elsevier）出版，2025 年影响因子为 6.7

Scope

• The journal covers medicinal chemistry and rational drug design该刊覆盖药物化学与理性药物设计
• Synthetic chemistry of bioactive molecules is a central subject活性分子的合成化学是核心主题
• Structure-activity relationships and molecular modelling are covered构效关系与分子模拟在其范围
• Bioinorganic and organometallic medicinal chemistry are within scope生物无机与有机金属药物化学同样收录
• Prodrugs, drug delivery and pharmacokinetics are published前药、给药系统与药代动力学均在发表之列
• Natural product inspired drug discovery is welcomed受天然产物启发的药物发现受到欢迎

History

• The journal was founded in 1974 as a European outlet for medicinal chemistry该刊 1974 年创办，是欧洲药物化学的学术园地
• It is published by Elsevier, whose French imprint has handled the title期刊由（Elsevier）出版，长期由其法国分支经办
• Its scope has expanded from classical synthetic medicinal chemistry towards chemical biology and drug discovery platforms其选题从经典合成药物化学扩展到化学生物学与药物发现平台
• The journal is published by Elsevier, under print ISSN 0223-5234, electronic ISSN 1768-3254该刊由（Elsevier）出版，印刷 ISSN 为 0223-5234，电子 ISSN 为 1768-3254。-
• Its Journal Impact Factor was 6.514 in 2021 and reached 6.7 in 2025, with the reported series 6.7, 5.9, 7.088, 6.514其影响因子由 2025 年的 6.7、2024 年的 5.9、2022 年的 7.088、2021 年的 6.514 等年度数据构成，最新为 2025 年的 6.7。

Editors

• An editor-in-chief coordinates regional and thematic editors主编统筹各地区与各主题方向的编辑
• The journal publishes original research, reviews and short communications期刊发表原创研究、综述与短通讯
• Special issues cover emerging therapeutic areas期刊以专刊覆盖新兴治疗领域
• It is indexed in the Science Citation Index Expanded, MEDLINE, Scopus and PubMed该刊被（Science Citation Index Expanded）、（MEDLINE）、（Scopus）与（PubMed）收录。